000 | 01159 a2200301 4500 | ||
---|---|---|---|
005 | 20250517213953.0 | ||
264 | 0 | _c20191024 | |
008 | 201910s 0 0 eng d | ||
022 | _a1873-4995 | ||
024 | 7 |
_a10.1016/j.jconrel.2018.05.001 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBöttger, Roland | |
245 | 0 | 0 |
_aPEGylated prodrugs of antidiabetic peptides amylin and GLP-1. _h[electronic resource] |
260 |
_bJournal of controlled release : official journal of the Controlled Release Society _c12 2018 |
||
300 |
_a58-66 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aHypoglycemic Agents _xchemistry |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aPeptides _xchemistry |
650 | 0 | 4 |
_aPolyethylene Glycols _xchemistry |
650 | 0 | 4 |
_aProdrugs _xchemistry |
650 | 0 | 4 |
_aSerum _xchemistry |
700 | 1 | _aKnappe, Daniel | |
700 | 1 | _aHoffmann, Ralf | |
773 | 0 |
_tJournal of controlled release : official journal of the Controlled Release Society _gvol. 292 _gp. 58-66 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jconrel.2018.05.001 _zAvailable from publisher's website |
999 |
_c28359939 _d28359939 |